NCT02989857 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 187
- units
- Participants
- groups
- description
- Participants received AG-120 500 mg, tablet, orally, QD in each 28-day treatment cycle, until occurrence of disease progression, unacceptable toxicity, confirmed pregnancy, death, subject withdrawal, lost to follow-up, or the sponsor ended the study for up to approximately 45 months.
- id
- BG000
- title
- AG-120
- description
- Participants received AG-120 matched placebo, orally, QD in each 28-day treatment cycle, until occurrence of disease progression, unacceptable toxicity, confirmed pregnancy, death, subject withdrawal, lost to follow-up or the sponsor ended the study for up to approximately 7 months. Participants who experienced disease progression and received placebo were allowed to cross over and receive AG-120.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.97
- value
- 60.3
- group Id
- BG001
- spread
- 10.38
- value
- 62.9
- group Id
- BG002
- spread
- 10.82
- value
- 61.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 119
- title
- Female
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 68
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 124
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- title
- Not Reported
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 52
- title
- Missing
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 23
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 71
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 106
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Other
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Not Reported
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 52
- title
- Missing
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Intent-To-Treat (ITT) Set included all participants who were randomized, with the treatment group designated according to the randomization.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 187
- units
- Participants
- groups
- description
- Participants received AG-120 500 mg, tablet, orally, QD in each 28-day treatment cycle, until occurrence of disease progression, unacceptable toxicity, confirmed pregnancy, death, subject withdrawal, lost to follow-up, or the sponsor ended the study for up to approximately 45 months.
- id
- BG000
- title
- AG-120
- description
- Participants received AG-120 matched placebo, orally, QD in each 28-day treatment cycle, until occurrence of disease progression, unacceptable toxicity, confirmed pregnancy, death, subject withdrawal, lost to follow-up or the sponsor ended the study for up to approximately 7 months. Participants who experienced disease progression and received placebo were allowed to cross over and receive AG-120.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.97
- value
- 60.3
- group Id
- BG001
- spread
- 10.38
- value
- 62.9
- group Id
- BG002
- spread
- 10.82
- value
- 61.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 119
- title
- Female
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 68
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 124
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- title
- Not Reported
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 52
- title
- Missing
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 23
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 71
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 106
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Other
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Not Reported
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 52
- title
- Missing
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Intent-To-Treat (ITT) Set included all participants who were randomized, with the treatment group designated according to the randomization.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle